Green Strategy to Develop Novel Drug-Containing Poly (<i>ε</i>-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications

<div>(a) Drug release profiles of the PCL-CS and PCL-CS-SiO<sub>2</sub> fibers and (b) SEM image of the PCL-CS-SiO<sub>2</sub> fibers after immersion in the SBF solution for 3 days.</div>

Journal of Nanomaterials

fig4

Figure 4

Figure 4: Green Strategy to Develop Novel Drug-Containing Poly (<i>ε</i>-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications 

Journal of Nanomaterials

Green Strategy to Develop Novel Drug-Containing Poly (ε-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications

Figure 4